Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
January 6, 2001
[Fabry's disease; towards a treatment]
G E Linthorst, C E Hollak, D K Bosman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1995
Increased basal glucose production in type 1 Gaucher's disease
E P Corssmit, C E Hollak, E Endert, et al.
The American Journal of Medicine
|
October 8, 1997
Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease
C E Hollak, E P Corssmit, J M Aerts, et al.
Biochimica Et Biophysica Acta
|
December 16, 1996
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease
H Michelakakis, C Spanou, A Kondyli, et al.
Journal of Inherited Metabolic Disease
|
February 11, 2005
Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease
J Brinkman, F A Wijburg, C E Hollak, et al.
JIMD Reports
|
August 13, 2016
Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency and Perioperative Management in Adult Patients
M M Welsink-Karssies, J A W Polderman, E J Nieveen van Dijkum, et al.
Lancet (London, England)
|
June 10, 1995
Individualised low-dose alglucerase therapy for type 1 Gaucher's disease
C E Hollak, J M Aerts, R Goudsmit, et al.
Journal of Inherited Metabolic Disease
|
March 21, 1998
Oligosaccharide excretion in adult Gaucher disease
J G de Jong, J M Aerts, S van Weely, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1995
Elevated plasma chitotriosidase activity in various lysosomal storage disorders
Y Guo, W He, A M Boer, et al.
Human Mutation
|
January 1, 1997
Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value
R G Boot, C E Hollak, M Verhoek, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nederlands Tijdschrift Voor Geneeskunde
|
January 6, 2001
[Fabry's disease; towards a treatment]
G E Linthorst, C E Hollak, D K Bosman, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1995
Increased basal glucose production in type 1 Gaucher's disease
E P Corssmit, C E Hollak, E Endert, et al.
The American Journal of Medicine
|
October 8, 1997
Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease
C E Hollak, E P Corssmit, J M Aerts, et al.
Biochimica Et Biophysica Acta
|
December 16, 1996
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease
H Michelakakis, C Spanou, A Kondyli, et al.
Journal of Inherited Metabolic Disease
|
February 11, 2005
Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease
J Brinkman, F A Wijburg, C E Hollak, et al.
JIMD Reports
|
August 13, 2016
Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency and Perioperative Management in Adult Patients
M M Welsink-Karssies, J A W Polderman, E J Nieveen van Dijkum, et al.
Lancet (London, England)
|
June 10, 1995
Individualised low-dose alglucerase therapy for type 1 Gaucher's disease
C E Hollak, J M Aerts, R Goudsmit, et al.
Journal of Inherited Metabolic Disease
|
March 21, 1998
Oligosaccharide excretion in adult Gaucher disease
J G de Jong, J M Aerts, S van Weely, et al.
Journal of Inherited Metabolic Disease
|
January 1, 1995
Elevated plasma chitotriosidase activity in various lysosomal storage disorders
Y Guo, W He, A M Boer, et al.
Human Mutation
|
January 1, 1997
Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value
R G Boot, C E Hollak, M Verhoek, et al.
Page
of 3